on September 28, 2006
Published online before print September 28, 2006, doi: 10.1161/01.STR.0000245088.60282.22
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 29, 2006
From Molecular Imaging Research Program (Y.C., Y.K., C.Y., H.O., Y.W., M.S., Y.W.), Frontier Research System, Institute of Physical and Chemical Research (RIKEN), Wako, Saitama, Japan; Department of Physiology (Y.C., Y.K., Y.W., Y.W.), Osaka City University Graduate School of Medicine, Osaka, Japan; Hamamatsu Pharma Research, Inc (H.T.), Hamamatsu, Shizuoka, Japan; Central Research Laboratory (T.K., H.O., H.T.), Hamamatsu Photonics K.K., Hamamatsu, Shizuoka, Japan; Department of Biomolecular Science (T.H., M.S.), Faculty of Engineering, Gifu University, Gifu, Japan; Department of Chemistry and Molecular Chirality Research Unit (R.N.), Nagoya University, Nagoya, Aichi, Japan. * To whom correspondence should be addressed. E-mail: yywata{at}med.osaka-cu.ac.jp.
Background and Purpose--Recently, we found that a novel subtype of prostacyclin (PGI2) receptor clearly distinct from the peripheral subtype in terms of ligand specificity is expressed in the central nervous system (CNS). (15R)-16-m-tolyl-17,18,19,20-tetranorisocarbacyclin (15R-TIC) was synthesized and demonstrated to be a specific ligand for this CNS-type PGI2 receptor. Previously, we demonstrated 15R-TIC to be neuroprotective in vivo during transient forebrain ischemia in gerbils and permanent middle cerebral artery occlusion (MCAO) in rats. Furthermore, this compound was shown to exert an anti-apoptotic effect on primary cultured hippocampal neurons, indicating its neuroprotective effect against ischemic insults occurs via direct action on CNS-type PGI2 receptor. Methods--Local cerebral hemodynamics and oxygen metabolism were measured simultaneously by using positron emission tomography with the 15O steady-state method, before and up to 18 hours after 3-hour transient MCAO reperfusion in cynomolgus monkeys. Methyl ester of 15R-TIC (50 µg/kg, n=4) or its vehicle (10% Intralipos, n=4) was injected intravenously within 5 minutes after onset of MCAO and continuously infused for 5 hours (50 µg/kg per hour). Results--Neuropathology showed that 15R-TIC significantly reduced cortical damage after 3-hour MCAO. Positron emission tomography results showed 15R-TIC significantly reduced the volume of "infarct" region of interest and attenuated the decrease in cerebral metabolic rate of oxygen and oxygen extraction fraction, and these protective effects were not attributable to improvement of cerebral circulation. Conclusions--These results suggest that 15R-TIC has a potent neuroprotective effect against focal cerebral ischemia in a monkey MCAO via its direct action on CNS-type PGI2 receptors.
Revised on August 2, 2006
Accepted on August 8, 2006
Neuroprotection by a Central Nervous System-Type Prostacyclin Receptor Ligand Demonstrated in Monkeys Subjected to Middle Cerebral Artery Occlusion and Reperfusion. A Positron Emission Tomography Study
Yilong Cui PhD;
Key words: cerebral blood flow • cerebral metabolic rate of oxygen • middle cerebral artery occlusion • oxygen extraction fraction • prostacyclin receptor